Clinical Trial Update: Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial by VTBIO Co. LTD investigated optimal dosage and administration for Alzheimer's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: VTBIO Co. LTD | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED